$VTAK News

Catheter Precision Announces Significant Commercial Growth Across Its LockeT And VIVO Product Lines Via New U.S. Distribution Channels, Premier Hospital Adoption And International Expansion

Catheter Precision's Flyte Subsidiary Surpasses Over 10K Consumer Accounts Registered On Flyte WebApp

Flyte Partners with The Nucleus Network for Inaugural Flagship Founder & Investor Event

Flyte Achieves Record Revenues in July

Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons

FLYTE Partners with 319 Golf Society and Named Exclusive Private Aviation Partner

Catheter Precision's Fly Flyte Subsidiary Collaborates With Blade Urban Air Mobility To Expand Client Reach, Raise Booking Opportunities, Enhance Aircraft Utilization

VTAK Announces Preliminary Second Quarter Record Revenue in Excess of $1 million

Catheter Precision Reports Preliminary Q2 Revenue Of $1.037M

Catheter Precision (VTAK) Stock Surges Over 19% After Hours: Why is it Moving?

Catheter Precision (VTAK) Stock Soars Nearly 27% After-Hours: Here's Why it is Trending

Catheter Precision, Inc. Announces Issuance of Two Key Patents

Flyte Announces Successful Launch of New Direct-to-Consumer Booking Platform

What's Going On With Catheter Precision Stock On Friday?

Catheter Precision (VTAK) Stock Jumps Over 17% After Hours: Here's What Is Going On

Catheter Precision Files Prospectus For Offering 68.07M Common Shares

Catheter Precision, Inc. Announces Allowance of Key Intellectual Property

Catheter Precision, Inc. Common Stock Q1 EPS $(1.39) Up From $(6.84) YoY, Sales $432.000K Up From $143.000K YoY

CATHETER PRECISION REPORTS 200% REVENUE GROWTH AND COMPLETES TRANSFORMATIVE FLYTE ACQUISITION

Catheter Precision Receives Notice Of Allowance From U.S. Patent And Trademark Office For Key Claims Covering Its Proprietary Surgical Vessel Closing Pressure Device